Aytu Biopharma (AYTU) Other Operating Expenses (2010 - 2026)

Aytu Biopharma (AYTU) has 17 years of Other Operating Expenses data on file, last reported at $6.7 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $6.7 million, up 9.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.9 million (up 30.58% YoY), and the FY2025 annual result was $32.9 million, up 27.5% from the prior year.
• Other Operating Expenses grew to $6.7 million in Q1 2026 per AYTU's latest filing, from $6.5 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $14.4 million in Q4 2022 and troughed at -$53.1 million in Q1 2022.
• A 5-year average of $3.4 million and a median of $6.5 million in 2025 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses surged 224.98% in 2022, then slumped 57.49% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $14.4 million in 2022, then tumbled by 57.49% to $6.1 million in 2023, then climbed by 0.93% to $6.2 million in 2024, then increased by 5.34% to $6.5 million in 2025, then climbed by 2.54% to $6.7 million in 2026.
• Business Quant data shows AYTU's Other Operating Expenses at $6.7 million in Q1 2026, $6.5 million in Q4 2025, and $5.8 million in Q3 2025.